For the Quarter Ending March 2026
Aspirin Prices in APAC
- In China, the Aspirin Price Index rose by 3.51% quarter-over-quarter, supporting tighter output and export demand.
- The average Aspirin price for the quarter was approximately USD 2532.67/MT on FOB Shanghai terms.
- Aspirin Spot Price firmed modestly as provincial wastewater inspections reduced immediate availability across East China.
- Aspirin Price Forecast suggests gains as export bookings and seasonal OTC demand sustain upward momentum.
- Aspirin Production Cost Trend showed feedstock fluctuations as Salicylic Acid spikes raised cash costs March.
- Aspirin Demand Outlook remains firm driven by domestic OTC needs and export orders to Americas.
- Aspirin Price Index movements were constrained by thin bonded inventories and timely shipments meeting lay-can windows.
- Temporary compliance shutdowns in Zhejiang and Shandong trimmed output, tightening spot supply and supporting FOB offers.
Why did the price of Aspirin change in March 2026 in APAC?
- Environmental compliance shutdowns reduced immediate output, tightening prompt availability and enabling exporters to lift offers.
- Salicylic Acid surged in March, raising acetylation cash costs and selectively pressuring finished-goods margins downstream.
- Robust export bookings from United States and Brazil absorbed cargoes, limiting inventory cushion, sustaining bids.
Aspirin Prices in Europe
- In Germany, the Aspirin Price Index rose by 5.30% quarter-over-quarter, driven by stronger import buying.
- The average Aspirin price for the quarter was approximately USD 2653.67/MT for CFR Hamburg shipments.
- Aspirin Spot Price firmed after certification premiums and reduced Asian prompt cargoes tightened Hamburg availability.
- Aspirin Price Forecast shows gains as distributors rebuild inventories while occasional Asian offers relieve pressure.
- Aspirin Production Cost Trend rose as salicylic acid and acetic anhydride increases lifted conversion costs.
- Aspirin Demand Outlook remains constructive with winter OTC peaks and steady hospital prophylaxis supporting procurement.
- Aspirin Price Index showed upward momentum as distributors restocked despite comfortable inventories and tighter offers.
- Environmental inspections and maintenance constrained Asian output, tightening spot lots and supporting firmer landed offers.
- Distributors' comfortable terminal stocks limited acute shortages, yet certification costs and transit delays elevated landed-costs.
Why did the price of Aspirin change in March 2026 in Europe?
- Higher salicylic acid costs and production audits raised conversion expenses, lifting import offers into Hamburg.
- Elevated winter OTC demand and hospital prophylaxis increased urgency, intensifying spot enquiries and distributor restocking.
- Certification fees and longer Asia-North Europe transit times added landed-costs, supporting firmer CFR Hamburg quotations.
Aspirin Prices in North America
- In the USA, the Aspirin Price Index rose by 2.53% quarter-over-quarter, reflecting feedstock-driven landed cost increases.
- The average Aspirin price for the quarter was approximately USD 2644.67/MT, reflecting CFRLosAngeles dynamics.
- Aspirin Spot Price remained contested as exporters sought to pass through higher salicylic acid costs.
- Aspirin Price Forecast indicates modest near-term gains as distributors replenish inventories ahead of seasonal demand.
- Aspirin Production Cost Trend tightened with phenol-driven salicylic acid increases, pressuring exporters' margin recovery efforts.
- Aspirin Demand Outlook remains balanced with winter OTC uplift offset by restrained preventive cardiology prescriptions.
- Aspirin Price Index shows stable trend supported by comfortable importer inventories and consistent export inquiry.
- West and Gulf Coast ports remained smooth, preventing logistics premiums and maintaining steady inbound flows.
Why did the price of Aspirin change in March 2026 in North America?
- Feedstock cost escalation: salicylic acid CFR Houston rose, elevating exporters' production cost and landed offers.
- Seasonal retail OTC demand absorbed incremental supply, supporting modest price increases despite conservative institutional prescribing.
- Ports operated normally and freight indices were unchanged, limiting logistics premiums and isolating feedstock inflation.
For the Quarter Ending December 2025
Aspirin Price in North America
- In USA, the Aspirin Price Index rose by 0.79% quarter-over-quarter, driven by tighter effective imports.
- The average Aspirin price for the quarter was approximately USD 2579.33/MT, reflecting sustained importer demand.
- Aspirin Spot Price stayed firm as Chinese, Indian FOB offers rose amid intensified compliance scrutiny.
- Aspirin Price Forecast indicates modest gains as restocking supports prices, tempered by steady inventories nationally.
- Aspirin Production Cost Trend shows slight upward pressure from higher precursor and compliance-related manufacturing expenses.
- Aspirin Demand Outlook remains seasonally strong with pharmacy restocking and stable cardiovascular usage supporting volumes.
- Aspirin Price Index rose as front-loaded buying and Asian offer adjustments pushed CFR levels higher.
- Inventory levels remained adequate overall, but cautious exporter allocations and maintenance reduced immediate spot availability.
Why did the price of Aspirin change in December 2025 in North America?
- Tighter Asian export offers and intensified GMP audits increased FOB costs, transmitting U.S. CFR values.
- Freight charges stayed neutral; marginal Asian upstream cost increases, not logistics, drove December price rise.
- Domestic restocking of contract resets and seasonal OTC demand increased importer purchases, supporting December momentum.
Aspirin Price in APAC
- In China, the Aspirin Price Index rose by 0.26% quarter-over-quarter in Q4 2025, after inspections.
- The average Aspirin price for the quarter was approximately USD 2446.67/MT reflecting modest cost inflation.
- Aspirin Production Cost Trend rose as utility costs and intermittent power curtailments elevated acetylation expenses.
- Aspirin Spot Price remained supported as exporters filled bookings ahead of winter demand, logistics disruptions.
- Aspirin Demand Outlook stays stable with hospital procurement and seasonal OTC purchases maintaining API off-take.
- Aspirin Price Forecast suggests upside into early 2026 if inspections ease and post-holiday production ramps.
- Low inventories and export demand kept discipline, supporting the Aspirin Price Index overall firmer pricing.
Why did the price of Aspirin change in December 2025 in APAC?
- Short environmental audits temporarily removed capacity in coastal plants, tightening spot availability and raising quotations.
- Seasonal OTC and hospital procurement ahead of winter absorbed cargoes, preventing inventory build-up among traders.
- Stable feedstock but higher utilities and logistics premiums nudged operating costs, supporting upward price pressure.
Aspirin Price in Europe
- In Germany, the Aspirin Price Index rose by 0.06% quarter-over-quarter, driven by tighter import availability.
- The average Aspirin price for the quarter was approximately USD 2520.00/MT, per importer CFR assessments.
- Aspirin Spot Price firmed as import offers tightened, reducing available volumes and lifting Price Index.
- Aspirin Price Forecast suggests modest gains into early 2026 supported by seasonality and freight normalization.
- Aspirin Production Cost Trend shows upward pressure from salicylic acid and acetic anhydride cost increases.
- Aspirin Demand Outlook remains firm with formulators and wholesalers restocking ahead of winter respiratory season.
- Inventory drawdowns and elevated import parity tightened export availability, keeping the Aspirin Price Index high.
- Regional manufacturers prioritized captive volumes, limiting market relief and supporting the firm Aspirin Spot Price.
Why did the price of Aspirin change in December 2025 in Europe?
- Tightened import allocations from China and India reduced spot availability, heightening landed CFR urgency perceptions.
- Freight normalization and seasonal surcharges raised landed costs, prompting buyers to accelerate purchases rebuild inventories.
- Domestic restocking and holiday production slowdowns tightened the immediate supply-demand balance, supporting higher Aspirin prices.
For the Quarter Ending September 2025
North America
- In USA, the Aspirin Price Index fell by 0.428% quarter-over-quarter, reflecting mild frontloading and cost pressures.
- The average Aspirin price for the quarter was approximately USD 2559.00/MT, reported across CFR Los Angeles shipments.
- Aspirin Spot Price softened in August as imports slowed and distributors reduced restocking to digest recent surges.
- Aspirin Price Forecast indicates mild recovery into Q4 driven by restocking and constrained logistics, per market consensus.
- Aspirin Production Cost Trend shows inflation-linked input increases, pressuring margins and supporting modest seller pricing discipline.
- Aspirin Demand Outlook remains steady domestically, but anticipatory buying and tariff uncertainty will create demand timing shifts.
- Aspirin Price Index volatility moderated as inventories stabilized, though export enquiries intermittently tightened availability for specific lots.
- Major US suppliers maintained allocations; port congestion eased, supporting smoother flows but preserving cautious seller allocation strategies.
Why did the price of Aspirin change in September 2025 in North America?
- Reduced import activity post-frontloading lowered immediate demand, easing spot upward pressure on domestic pricing levels.
- Logistics stability decreased freight and handling costs, allowing suppliers offer moderated prices to clear inventory.
- Tariff uncertainty prompted earlier frontloading, then demand lull in September as buyers paused further purchasing.
APAC
- In China, the Aspirin Price Index fell by 0.80% quarter-over-quarter, reflecting subdued export demand pressures.
- The average Aspirin price for the quarter was approximately USD 2440.33/MT, reported FOB Shanghai levels.
- Aspirin Spot Price softened as frontloaded shipments left elevated inventories, dampening buyer urgency and activity.
- Aspirin Price Forecast suggests recovery in Q4 as restocking resumes and seasonal export demand strengthens.
- Aspirin Production Cost Trend rose due to higher freight, weather disruptions, and constrained feedstock availability.
- Aspirin Demand Outlook indicates cautious buying as buyers pace orders ahead of tariff suspension expiry.
- Aspirin Price Index remains rangebound as manufacturers maintain moderate capacity, avoiding speculative production increases later.
- Export demand tightened earlier then softened, with inventories stabilizing, supporting only limited upward price momentum.
Why did the price of Aspirin change in September 2025 in APAC?
- Frontloaded shipments earlier in summer created inventory overhang, reducing urgent buying and softening export prices.
- Shipping disruptions and slow port recoveries increased lead times, discouraging orders and pressuring seller margins.
- Higher freight and seasonal weather-driven production constraints elevated production costs, prompting price adjustments by exporters.
Europe
- In Germany, the Aspirin Price Index fell by 0.853% quarter-over-quarter, reflecting shipping congestion and restocking.
- The average Aspirin price for the quarter was approximately USD 2518.33/MT across CFR Hamburg shipments.
- Aspirin Spot Price volatility eased as port congestion caused uneven arrivals and localized premium bids.
- Aspirin Price Forecast anticipates modest Q4 recovery as carriers normalize schedules and inventories slowly stabilize.
- Aspirin Production Cost Trend shows higher freight and inland transport raising landed costs for distributors.
- Aspirin Demand Outlook remains steady; buyers pause after frontloading, then cautiously resume routine replenishment activities.
- Aspirin Price Index movements reflected inventory digestion, selective export enquiries and suppliers' cautious allocation practices.
- Major producers operated normally, but transportation constraints limited volumes for spot and contract market demand
Why did the price of Aspirin change in September 2025 in Europe?
- Persisting port congestion extended lead times, elevating landed costs and reducing availability for European importers.
- Pre-buying earlier in summer created temporary inventory buffers, reducing immediate spot demand and softening prices.
- Freight surcharges and Rhine low water increased transport costs, squeezing margins and prompting supplier allocations.
For the Quarter Ending June 2025
North America
- The Aspirin Spot Price in the USA declined sharply in April 2025, with the Price Index registering a -6.91% decrease due to high inventory levels, tariff frontloading, and reduced downstream demand.
- In April, large-scale inventory buildup, triggered by pre-emptive procurement ahead of the 145% tariff implementation, suppressed immediate demand, leading to limited restocking and significant Price Index erosion.
- Despite steep tariffs on Chinese imports, many U.S. market participants absorbed the initial impact, contributing to a soft Product Price Forecast for April as buyers cut prices to reduce overstocked inventory.
- In May 2025, the Price Index increased marginally by 0.39% as a temporary 90-day suspension of tariffs until August 14 prompted a surge in shipments from China, creating freight and port congestion issues.
- Peak Season Surcharges and logistic bottlenecks in May intensified the Product Production Cost Trend, pushing up freight expenses and influencing a short-lived upward movement in prices.
- On the demand front, U.S. pharmaceutical buyers accelerated purchases in May to beat the August tariff deadline, reflecting a robust Product Demand Outlook and precautionary inventory buildup.
- June 2025 saw another modest 0.39% Price Index increase as buyers continued forward procurement under favorable tariff conditions, compounding short-term pressure on the supply chain.
- Rising inflation in June led firms to hedge against future cost hikes by purchasing early, tightening availability and influencing a firmer Product Price Forecast.
- Overall, Q2 witnessed alternating pricing patterns: April marked a price correction due to oversupply, while May and June rebounded slightly on logistical disruptions and inflation-adjusted buying.
- In July 2025, Aspirin prices are likely to decrease, as the inventory built up from Q2 forward buying starts to stabilize. Traders are expected to offer discounts to move excess stock before August restocking begins, reducing near-term pricing strength.
APAC
- In April 2025, the Price Index of Aspirin (USP, FDA) FOB Shanghai dropped by 3.92%, primarily due to weak international demand, a sharp contraction in China’s manufacturing PMI to 49.0, and heavy port congestion affecting pharmaceutical logistics.
- The Aspirin Spot Price decline was amplified by a steep 145% U.S. tariff on Chinese pharmaceuticals, triggering mass cancellations and order delays, as foreign buyers slashed offtake in favor of alternative markets or existing inventories.
- High Aspirin production costs from previous manufacturing upswings remained unrecovered due to poor sales performance, forcing suppliers to offer deep discounts amid bloated inventories and subdued Product Demand Outlook.
- By May 2025, the market recovered slightly, with the Price Index increasing by 0.41% month-on-month as overseas buyers rushed to frontload orders before the U.S. tariff reprieve ends in August, triggering a surge in shipping rates and a spike in demand.
- The rebound in Product Spot Price was also supported by rising raw material (salicylic acid) costs and limited container availability, which caused distribution lead times to contract and improved turnover for Chinese exporters.
- Exporters benefited from General Rate Increases (GRIs) in ocean freight and peak season surcharges beginning June 1, incentivizing advance bookings, leading to stronger pricing confidence and improved Product Price Forecast for the near term.
- In June 2025, the Price Index again rose marginally by 0.41%, as international buyers accelerated purchases to meet summer formulation schedules and mitigate against future price hikes once tariff benefits expire.
- Product Demand Outlook in June remained stable, backed by sustained U.S. interest and consistent procurement from downstream pharma manufacturers, encouraging modest increases in factory utilization and export-driven production.
- Despite the short-term uplift, manufacturers remained cautious, avoiding overexpansion amid uncertain global trade policies and volatile freight conditions, maintaining a measured stance on Product Production Cost Trend.
- In July 2025, a mild price decrease is expected, as some international buyers pause purchasing after fulfilling forward orders in Q2. The market may see a temporary correction as players adopt a wait-and-watch strategy ahead of the August tariff deadline.
Europe
- The Aspirin Spot Price in Germany declined by 6.30% in April 2025, as the Price Index was pressured by oversupply stemming from US-bound cargo diversions and pre-holiday stockpiling.
- A consistent stream of Asian imports, strong shipping capacity, and advance purchases before the May Day break amplified the supply glut, weakening the Product Price Forecast.
- Subdued Product Demand Outlook and port congestion at Hamburg and Rotterdam delayed offtake, prompting sellers to cut prices to stimulate buying interest.
- In May, the Price Index rebounded by 0.40% as worsening Northern European port congestion and reduced vessel space restricted supply.
- Carriers redirected vessels to the Trans-Pacific route after US tariff adjustments, reducing capacity on Asia–Europe routes and tightening German imports.
- Rising bookings in late May, ahead of June GRIs, fueled spot buying, reinforcing bullish sentiment in the Product Price Forecast.
- By June, continued port delays and Rhine River logistics hurdles pushed the Price Index up by another 0.39%, despite Germany's easing inflation (2%).
- Early restocking and supply disruption fears led to short-term tightening, despite steady end-use demand from pharmaceutical buyers.
- The Product Production Cost Trend remained stable, but importers paid higher landed costs to secure timely delivery amid unpredictability.
- In July 2025, prices are likely to decrease slightly as excess June inventory stabilizes and resellers offer markdowns to clear stock ahead of August.
